Literature DB >> 34311734

Differential disease phenotypes and progression in relapsing-remitting multiple sclerosis: comparative analyses of single Canadian and Saudi Arabian clinics.

M Alluqmani1,2, W Roda3, M Qqrmli2, G Blevins1, F Giuliani1, C Power4.   

Abstract

OBJECTIVE: Relapsing-remitting multiple sclerosis (RR-MS) phenotypes differ widely although the variables contributing to this heterogeneity remain uncertain. To assess geographic and ethnic effects on RR-MS phenotypes, we investigated RR-MS patients in Canada and Saudi Arabia.
METHODS: A retrospective analysis of patients followed in two MS Clinics was performed in Medina, Saudi Arabia and Edmonton, Canada. Demographic and clinical data were collected for each patient and analyzed using univariable and multivariable statistics. Univariable and multivariable linear regression were used to distinguish the significant clinical and demographic features and neurological systems associated with the change in expanded disability status scale (EDSS) between clinical assessments.
RESULTS: Patients with treated RR-MS were recruited (n = 51, Saudi; n = 47, Canada) although the disease duration was longer in the Canadian cohort (5.6 ± 2.2 yr.) compared to the Saudi cohort (4.4 ± 1.4 yr.) (P < 0.05), annual relapse rate and EDSS change were higher in the Saudi cohort (P < 0.05). Infratentorial lesion-associated presentation differed (Canada, n = 23; Saudi, n = 13) among groups (P < 0.05). Spinal cord lesions on MRI were more frequently detected in Canadian (n = 23) compared to Saudi (n = 1) patients (P < 0.05). Patients within the Saudi cohort displayed a significantly greater change in Expanded Disability Status Scale (EDSS) between first and second assessments.
CONCLUSIONS: Despite differences in geographic location, ethnicity, and predominance of infratentorial lesions in the Canadian group, the RR-MS phenotypes were similar although the Saudi cohort displayed a more severe disease course.
© 2021. The Author(s).

Entities:  

Keywords:  Disease modifying therapy; Disease progression; Geography; Relapsing–remitting multiple sclerosis; Statistical analyses

Year:  2021        PMID: 34311734     DOI: 10.1186/s12883-021-02317-2

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  3 in total

1.  [Genetic factors in multiple sclerosis and neuromyelitis optica].

Authors:  Shinya Sato; Jun-Ichi Kira
Journal:  Nihon Rinsho       Date:  2014-11

2.  Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt.

Authors:  Hamdy Na El Tallawy; Wafaa Ma Farghaly; Tarek A Rageh; Ghaydaa A Shehata; Reda Badry; Nabil A Metwally; Esam A El Moselhy; Mahmoud Hassan; Mohamed A Sayed; Ahmed A Waris; Yaser Hamed; Islam Shaaban; Mohamed A Hamed; Mahmoud Raafat Kandil
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-27       Impact factor: 2.570

3.  The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan.

Authors:  Walter J Hader; Irene M Yee
Journal:  Mult Scler Int       Date:  2014-02-03
  3 in total
  1 in total

1.  The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia.

Authors:  Seraj Makkawi; Fahad A AlHarbi; Nedaa Alsulaimani; Reem Brashi; Renad Melebary; Shuaa Aljabri; Khalid F Altowairqi; Albaraa F Ashoor; Amal Alkhotani
Journal:  Cureus       Date:  2022-04-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.